With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) Scientists have warned it's impossible to predict which avian influenza virus will spark the next pandemic, and while most of the attention has been on highly pathogenic H5N1, one research group is reporting new findings that raise concerns about the threat from the low-pathogenic H9N2 virus.
(CIDRAP News) A new report from the British government ranks pandemic influenza very high on the list of major security threats to the United Kingdom.
(CIDRAP News) Two pharmaceutical companies that are developing a second-generation version of the inhaled antiviral drug zanamivir (Relenza) reported promising phase 2 results showing that one dose was as effective against influenza as a course of oseltamivir (Tamiflu).
(CIDRAP News) – In the history of infectious diseases, coincidence plays an extraordinary role. In 1706, Cotton Mather purchased a slave named Onesimus who happened to come from a tribe that practiced variolation, and so smallpox prevention was introduced to North America.
(CIDRAP News) The Government Accountability Office (GAO) released a status report yesterday on progress states have made toward preparing for a flood of people needing medical care in the wake of an event such as a terrorist attack or an influenza pandemic.
(CIDRAP News) A Japanese health ministry official said today that a government-supported study has found no evidence that the antiviral drug oseltamivir (Tamiflu) causes abnormal behavior in young people, according to a Reuters report.
(CIDRAP News) A study from Indiana reveals a long list of problems hampering county-level planning for pandemic influenza, ranging from misunderstanding of the threat and lack of coordination and resources to rivalry between hospital systems.
Editor's Note: CIDRAP's Public Health Practices online database showcases expert-reviewed practices, including useful tools to help others. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning and response.
(CIDRAP News) With an endorsement from US health officials, Roche, maker of the antiviral drug oseltamivir (Tamiflu), today unveiled a program to encourage more businesses to stockpile the drug to protect employees in case of an influenza pandemic.
(CIDRAP News) Eighty-three children in the United States died of influenza during the past flu season, the Centers for Disease Control and Prevention (CDC) said today in a report confirming previous indications that the season was a relatively rough one.
